Acebutolol hydrochloride

Acebutolol hydrochloride Basic information
Product Name:Acebutolol hydrochloride
Synonyms:ACEBUTOLOL HCL;ACEBUTOLOL HYDROCHLORIDE;N-[3-ACETYL-4-(2-HYDROXY-3-[ISOPROPYLAMINO]PROPOXY)PHENYL]-BUTANAMIDE HYDROCHLORIDE;n-[3-acetyl-4-[2-hydroxy-3-[(isopropyl)amino]propoxy]phenyl]butyramide hydrochloride;3’-Acetyl-4’-(2-Hydroxy-3-(Isopropylamino)Prop;Acebutolol hydrochloride,N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide;Acebutolol Hydrochloride (125 mg);Acebutolol Hydrochloride iMpurity A
CAS:34381-68-5
MF:C18H29ClN2O4
MW:372.89
EINECS:251-980-3
Product Categories:AVODART;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:34381-68-5.mol
Acebutolol hydrochloride Structure
Acebutolol hydrochloride Chemical Properties
Melting point 141-1430C
storage temp. 2-8°C
solubility Freely soluble in water and in ethanol (96 per cent), very slightly soluble in acetone and in methylene chloride.
form neat
color White to Pale Yellow
InChIKeyKTUFKADDDORSSI-UHFFFAOYSA-N
CAS DataBase Reference34381-68-5(CAS DataBase Reference)
Safety Information
Hazard Codes Xn
Risk Statements 20/21/22
Safety Statements 36
WGK Germany 3
RTECS ES5235000
HS Code 2924296000
Hazardous Substances Data34381-68-5(Hazardous Substances Data)
ToxicityLD50 orl-rat: 6620 mg/kg OYYAA2 20,883,80
MSDS Information
ProviderLanguage
SigmaAldrich English
Acebutolol hydrochloride Usage And Synthesis
Chemical PropertiesOff-White Powder
OriginatorSectral ,May and Baker ,UK ,1975
UsesCardioselective ?adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II)
UsesCardioselective β-adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II).
Uses5-alpha-reductase inhibitor
DefinitionChEBI: The hydrochloride salt of acebutolol, prepared using equimolar amounts of acebutolol and hydrogen chloride.
Manufacturing ProcessCrude 5'-butyramido-2'-(2,3-epoxypropoxy)acetophenone (16 g), isopropylamine (20 g) and ethanol (100 ml) were heated together under reflux for 4 hours. The reaction mixture was concentrated under reduced pressure and the residual oil was dissolved in N hydrochloric acid. The acid solution was extracted with ethyl acetate, the ethyl acetate layers being discarded. The acidic solution was brought to pH 11 with 2 N aqueous sodium hydroxide solution and then extracted with chloroform. The dried chloroform extracts were concentrated under reduced pressure to give an oil which was crystallized from a mixture of ethanol and diethyl ether to give 5'-butyramido- 2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone (3 g), MP 119-123°C.
Crude 5'-butyramido-2'-(2,3-epoxypropoxy)acetophenone used as starting material was prepared as follows: p-butyramidophenol (58 g; prepared according to Fierz-David and Kuster, Helv. Chim. Acta 1939,2282), acetyl chloride (25.4 g) and benzene (500 ml) were heated together under reflux until a solution formed (12 hours). This solution was cooled and treated with water. The benzene layer was separated and the aqueous layer was again extracted with benzene.
The combined benzene extracts were dried and evaporated to dryness under reduced pressure to give p-butyramidophenyl acetate (38 g) as an off-white solid, MP 102-103°C. A mixture of p-butyramidophenyl acetate (38 g), aluminum chloride (80 g) and 1,1,2,2-tetrachloroethane (250 ml) was heated at 140°C for 3 hours. The reaction mixture was cooled and treated with iced water. The tetrachloroethane layer was separated and the aqueous layer was extracted with chloroform. The combined organic layers were extracted with 2 N aqueous sodium hydroxide and the alkaline solution was acidified to pH 5 with concentrated hydrochloric acid. The acidified solution was extracted with chloroform and the chloroform extract was dried and concentrated under reduced pressure to give 5'-butyramido-2'-hydroxyacetophenone (15.6 g), MP 114-117°C. A solution of 5'-butyramido-2'-hydroxyacetophenone (15.6 g) in ethanol (100 ml) was added to an ethanolic solution of sodium ethoxide which was prepared from sodium (1.62 g) and ethanol (100 ml). The resulting solution was evaporated to dryness under reduced pressure and dimethylformamide (100 ml) was added to the solid residue. Approximately 10 ml of dimethylformamide was removed by distillation under reduced pressure. Epichlorohydrin (25 ml) was added and the solution was heated at 100°C for 4 hours. The solution was concentrated under reduced pressure to give a residual oil which was treated with water to give a solid. The solid was dissolved in ethanol and the resulting solution was treated with charcoal, filtered and concentrated under reduced pressure to give crude 5'-butyramido- 2'-(2,3-epoxypropoxy)acetophenone (16 g), MP 110-116°C.
The crude compound may be purified by recrystallization from ethyl acetate, after treatment with decolorizing charcoal, to give pure 5'-butyramido-2'-(2,3- epoxypropoxy)acetophenone, MP 136-138°C.


Brand nameSectral (Dr. Reddy’s).
Therapeutic Functionbeta-Adrenergic blocker
Safety ProfilePoison by ingestion, subcutaneous,intravenous, and intraperitoneal routes. An experimentalteratogen. Other experimental reproductive effects. Whenheated to decomposition it emits toxic fumes of NOx andHCl.
Acebutolol hydrochloride Preparation Products And Raw materials
Raw materialsIsopropylamine-->Acetyl chloride-->Sodium ethoxide-->Aluminum chloride-->Epichlorohydrin
5'-Amino-2'-hydroxyacetophenone 1-AMINO-3-PHENOXY-PROPAN-2-OL 3-O-TOLYLOXY-PROPYLAMINE N-[3-ACETYL-4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]BUTANAMIDE CHEMBRDG-BB 5623290 Diacetolol Acebutolol hydrochloride METHYL-(3-O-TOLYLOXY-PROPYL)-AMINE CHEMBRDG-BB 5482082 Practolol Ethanone, 1-(5-amino-2-methoxyphenyl)- (9CI) 3'-Acetamidoacetophenone AKOS BBS-00007965 1-METHYLAMINO-3-PHENOXY-PROPAN-2-OL N-(4-propoxyphenyl)acetamide N1-(3-ACETYL-4-HYDROXYPHENYL)ACETAMIDE 2-Acetyl-4-butyramidophenol 1-(5-BUTYLAMINO-2-HYDROXY-PHENYL)-ETHANONE Acebutolol Hcl

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.